Characterization of the bone phenotype in ClC-7-deficient mice

Calcified Tissue International

Volumn 83, Issue 6, 2008, Pages 425-437

  Neutzsky Wulff, Anita Vibsig ^a   Karsdal, Morten A ^a   Henriksen, Kim ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

Author keywords

Acidification; ClC 7; Clcn7; Coupling; Osteoclast; Osteopetrosis

Indexed keywords

ACRIDINE ORANGE; ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; CHLORIDE CHANNEL; CHLORIDE CHANNEL 7; PHOSPHATASE; TARTATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

ACIDIFICATION; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE MATRIX; CHEMICAL ANALYSIS; CONTROLLED STUDY; MEMBRANE VESICLE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; WILD TYPE;

ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; BONE RESORPTION; CARTILAGE; CHLORIDE CHANNELS; EXONS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOCLASTS; OSTEOPETROSIS; PHENOTYPE; SPLEEN;

EID: 57249097079     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-008-9185-7     Document Type: Article

References (55)

1. TJ Martin 1993 Hormones in the coupling of bone resorption and formation Osteoporos Int 3 Suppl 1 121 125
2. Martin TJ, Rodan GA (2001) Coupling of bone resorption and formation during bone remodeling. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis, 2nd edn. Academic Press, San Diego, pp 361-370
3. D Goltzman 2002 Discoveries, drugs and skeletal disorders Nat Rev Drug Discov 1 784 796
4. SL Teitelbaum FP Ross 2003 Genetic regulation of osteoclast development and function Nat Rev Genet 4 638 649
5. GD Roodman 1999 Cell biology of the osteoclast Exp Hematol 27 1229 1241
6. K Henriksen MG Sorensen RH Nielsen J Gram S Schaller MH Dziegiel V Everts J Bollerslev MA Karsdal 2006 Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification J Bone Miner Res 21 58 66
7. R Baron L Neff D Louvard PJ Courtoy 1985 Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border J Cell Biol 101 2210 2222
8. HC Blair SL Teitelbaum R Ghiselli S Gluck 1989 Osteoclastic bone resorption by a polarized vacuolar proton pump Science 245 855 857
9. A Frattini PJ Orchard C Sobacchi S Giliani M Abinun JP Mattsson DJ Keeling AK Andersson P Wallbrandt L Zecca LD Notarangelo P Vezzoni A Villa 2000 Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis Nat Genet 25 343 346
10. +-ATPase type in the ruffled borders of osteoclasts J Cell Biol 111 1305 1311
11. TJ Jentsch 2007 Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters J Physiol 578 633 640
12. TJ Jentsch V Stein F Weinreich AA Zdebik 2002 Molecular structure and physiological function of chloride channels Physiol Rev 82 503 568
13. U Kornak D Kasper MR Bosl E Kaiser M Schweizer A Schulz W Friedrich G Delling TJ Jentsch 2001 Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man Cell 104 205 215
14. TJ Jentsch I Neagoe O Scheel 2005 CLC chloride channels and transporters Curr Opin Neurobiol 15 319 325
15. - channels Nature 427 803 807
16. A Picollo M Pusch 2005 Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5 Nature 436 420 423
17. O Scheel AA Zdebik S Lourdel TJ Jentsch 2005 Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins Nature 436 424 427
18. + antiporter ClC-7 is the primary chloride permeation pathway in lysosomes Nature 453 788 792
19. PF Lange L Wartosch TJ Jentsch JC Fuhrmann 2006 ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function Nature 440 220 223
20. W Balemans L Van Wesenbeeck W Van Hul 2005 A clinical and molecular overview of the human osteopetroses Calcif Tissue Int 77 263 274
21. MH Helfrich 2003 Osteoclast diseases Microsc Res Tech 61 514 532
22. +-ATPase enzyme system Front Biosci 10 2940 2954
23. J Tolar SL Teitelbaum PJ Orchard 2004 Osteopetrosis N Engl J Med 351 2839 2849
24. A Frattini A Pangrazio L Susani C Sobacchi M Mirolo M Abinun M Andolina A Flanagan EM Horwitz E Mihci LD Notarangelo U Ramenghi A Teti J Van Hove D Vujic T Young A Albertini PJ Orchard P Vezzoni A Villa 2003 Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis J Bone Miner Res 18 1740 1747
25. SL Alatalo KK Ivaska SG Waguespack MJ Econs HK Vaananen JM Halleen 2004 Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis) Clin Chem 50 883 890
26. J Bollerslev T Steiniche F Melsen L Mosekilde 1989 Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types Bone 10 19 24
27. A Del Fattore B Peruzzi N Rucci I Recchia A Cappariello M Longo D Fortunati P Ballanti M Iacobini M Luciani R Devito R Pinto M Caniglia E Lanino C Messina S Cesaro C Letizia G Bianchini H Fryssira P Grabowski N Shaw N Bishop D Hughes RP Kapur HK Datta A Taranta R Fornari S Migliaccio A Teti 2006 Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment J Med Genet 43 315 325
28. MA Karsdal TJ Martin J Bollerslev C Christiansen K Henriksen 2007 Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 22 487 494
29. MA Karsdal K Henriksen MG Sorensen J Gram S Schaller MH Dziegiel AM Heegaard P Christophersen TJ Martin C Christiansen J Bollerslev 2005 Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption Am J Pathol 166 467 476
30. MA Karsdal AV Neutzsky-Wulff MH Dziegiel C Christiansen K Henriksen 2008 Osteoclasts secrete non-bone derived signals that induce bone formation Biochem Biophys Res Commun 366 483 488
31. TJ Martin NA Sims 2005 Osteoclast-derived activity in the coupling of bone formation to resorption Trends Mol Med 11 76 81
32. D Kasper R Planells-Cases JC Fuhrmann O Scheel O Zeitz K Ruether A Schmitt M Poet R Steinfeld M Schweizer U Kornak TJ Jentsch 2005 Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration EMBO J 24 1079 1091
33. B Winding R NicAmhlaoibh H Misander P Hoegh-Andersen TL Andersen C Holst-Hansen AM Heegaard NT Foged N Brunner JM Delaisse 2002 Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice Clin Cancer Res 8 1932 1939
34. LA Ridnour AN Windhausen JS Isenberg N Yeung DD Thomas MP Vitek DD Roberts DA Wink 2007 Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways Proc Natl Acad Sci USA 104 16898 16903
35. BC Sondergaard K Henriksen H Wulf S Oestergaard U Schurigt R Brauer I Danielsen C Christiansen P Qvist MA Karsdal 2006 Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation Osteoarthritis Cartilage 14 738 748
36. JC Edwards C Cohen W Xu PH Schlesinger 2006 c-Src control of chloride channel support for osteoclast HCl transport and bone resorption J Biol Chem 281 28011 28022
37. MG Sorensen K Henriksen AV Neutzsky-Wulff MH Dziegiel MA Karsdal 2007 Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption J Bone Miner Res 22 1640 1648
38. K Henriksen M Karsdal JM Delaisse MT Engsig 2003 RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism J Biol Chem 278 48745 48753
39. MA Karsdal P Hjorth K Henriksen T Kirkegaard KL Nielsen H Lou JM Delaisse NT Foged 2003 Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression J Biol Chem 278 44975 44987
40. K Henriksen J Gram P Høegh-Andersen R Jemtland T Ueland MH Dziegiel S Schaller J Bollerslev MA Karsdal 2005 Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo Am J Pathol 167 1341 1348
41. K Henriksen LB Tanko P Qvist PD Delmas C Christiansen MA Karsdal 2007 Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases Osteoporos Int 18 681 685
42. E Cleiren O Benichou E Van Hul J Gram J Bollerslev FR Singer K Beaverson A Aledo MP Whyte T Yoneyama MC De Vernejoul W Van Hul 2001 Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene Hum Mol Genet 10 2861 2867
43. SG Waguespack DL Koller KE White T Fishburn G Carn KA Buckwalter M Johnson M Kocisko WE Evans T Foroud MJ Econs 2003 Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II J Bone Miner Res 18 1513 1518
44. K Henriksen J Gram S Schaller BH Dahl MH Dziegiel J Bollerslev MA Karsdal 2004 Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II Am J Pathol 164 1537 1545
45. K Chu R Snyder MJ Econs 2006 Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties J Bone Miner Res 21 1089 1097
46. HC Blair CW Borysenko A Villa PH Schlesinger SE Kalla BB Yaroslavskiy V Garcia-Palacios JI Oakley PJ Orchard 2004 In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects J Bone Miner Res 19 1329 1338
47. C Letizia A Taranta S Migliaccio C Caliumi D Diacinti E Delfini E D'Erasmo M Iacobini M Roggini OM Albagha SH Ralston A Teti 2004 Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations Calcif Tissue Int 74 42 46
48. RH Nielsen MA Karsdal MG Sorensen MH Dziegiel K Henriksen 2007 Dissolution of the inorganic phase of bone leading to release of calcium regulates osteoclast survival Biochem Biophys Res Commun 360 834 839
49. J Bollerslev SC Marks Jr S Pockwinse M Kassem K Brixen T Steiniche L Mosekilde 1993 Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis Bone 14 865 869
50. +-ATPase of avian osteoclast ruffled membrane Am J Physiol Cell Physiol 260 C1315 C1324
51. S Schaller K Henriksen C Sveigaard AM Heegaard N Helix M Stahlhut MC Ovejero JV Johansen H Solberg TL Andersen D Hougaard M Berryman CB Shiodt BH Sorensen J Lichtenberg P Christophersen NT Foged JM Delaisse MT Engsig MA Karsdal 2004 The chloride channel inhibitor n53736 prevents bone resorption in ovariectomized rats without changing bone formation J Bone Miner Res 19 1144 1153
52. + antiporter ClC-7 is the primary chloride permeation pathway in lysosomes Nature 453 788 792
53. P Garnero M Ferreras MA Karsdal R NicAmhlaoibh J Risteli O Borel P Qvist PD Delmas NT Foged JM Delaisse 2003 The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation J Bone Miner Res 18 859 867
54. R Kiviranta J Morko SL Alatalo R NicAmhlaoibh J Risteli T Laitala-Leinonen E Vuorio 2005 Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio Bone 36 159 172
55. JM Delaisse MT Engsig V Everts OM del Carmen M Ferreras L Lund TH Vu Z Werb B Winding A Lochter MA Karsdal T Troen T Kirkegaard T Lenhard AM Heegaard L Neff R Baron NT Foged 2000 Proteinases in bone resorption: obvious and less obvious roles Clin Chim Acta 291 223 234